Targetable HPMA Copolymer–Aminohexylgeldanamycin Conjugates for Prostate Cancer Therapy
✍ Scribed by Mark P. Borgman; Abhijit Ray; Rohit B. Kolhatkar; Edward A. Sausville; Angelika M. Burger; Hamidreza Ghandehari
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 345 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Biodistribution, pharmacokinetics, and efficacy of prostate‐cancer‐targeted HPMA copolymer/DTX conjugates are evaluated in nude mice bearing prostate cancer C4‐2 xenografts. PSMA‐specific monoclonal antibodies 3F/11 are used as the targeting moiety. Control conjugates contain either non
## Abstract It is becoming increasingly clear that angiogenesis plays a crucial role in prostate cancer (CaP) survival, progression, and metastasis. Tumor angiogenesis is a hallmark of advanced cancers and an attractive treatment target in multiple solid tumors. By understanding the molecular basis
## Background: Previous studies have shown that herpes simplex virus thymidine kinase (hsv-tk)/ganciclovir (gcv) comprised the most commonly used suicide gene therapy for prostate cancer, with modest results being obtained. however, novel suicide genes, such as escherichia coli purine nucleoside ph